|
APITD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56665824547053E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84550161211428E-13 |
| Normal-vs-Stage2 |
2.970400E-02 |
| Normal-vs-Stage3 |
1.43730000123909E-08 |
| Normal-vs-Stage4 |
1.4933609904233E-12 |
| Stage1-vs-Stage2 |
1.901850E-03 |
| Stage1-vs-Stage3 |
6.449800E-01 |
| Stage1-vs-Stage4 |
1.350330E-02 |
| Stage2-vs-Stage3 |
2.501200E-03 |
| Stage2-vs-Stage4 |
2.4665999999951E-05 |
| Stage3-vs-Stage4 |
1.357620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.25135490647699E-14 |
| Normal-vs-AfricanAmerican |
1.586940E-04 |
| Normal-vs-Asian |
5.11279996118219E-09 |
| Caucasian-vs-AfricanAmerican |
4.639600E-01 |
| Caucasian-vs-Asian |
7.091400E-01 |
| AfricanAmerican-vs-Asian |
6.561800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32759999660337E-08 |
| Normal-vs-Female |
5.29054577924626E-12 |
| Male-vs-Female |
6.063600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.09658981684424E-12 |
| Normal-vs-Age(41-60Yrs) |
3.08590000219766E-08 |
| Normal-vs-Age(61-80Yrs) |
2.33890000000958E-06 |
| Normal-vs-Age(81-100Yrs) |
5.033000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.542100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.972350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.244600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.935400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.825000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.909600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.10829999999218E-05 |
| Classical-VS-Follicular |
5.60719999986858E-07 |
| Classical-VS-Other |
9.856400E-01 |
| Classical-VS-Normal |
1.65878422109245E-12 |
| Tall-VS-Follicular |
4.2632564145606E-12 |
| Tall-VS-Other |
1.591840E-01 |
| Tall-VS-Normal |
8.88178419700125E-16 |
| Follicular-VS-Other |
1.150430E-01 |
| Follicular-VS-Normal |
1.572310E-02 |
| Other-VS-Normal |
4.642900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.62100000054156E-07 |
| Normal-vs-N1 |
1.46549439250521E-14 |
| N0-vs-N1 |
1.37320000037633E-07 |
|
|
